Ortega C - Search Results

1

Contrast Enhanced CT Radiogenomics in a Retrospective NSCLC Cohort: Models, Attempted Validation of a Published Model and the Relevance of the Clinical Context.

Kohan A, Hinzpeter R, Kulanthaivelu R, Mirshahvalad SA, Avery L, Tsao M, Li Q, Ortega C, Metser U, Hope A, Veit-Haibach P. Kohan A, et al. Among authors: ortega c. Acad Radiol. 2024 Feb 20:S1076-6332(24)00053-9. doi: 10.1016/j.acra.2024.01.031. Online ahead of print. Acad Radiol. 2024. PMID: 38383258 Free article.

2

¹⁸F-DCFPyL PET/CT in Patients with Subclinical Recurrence of Prostate Cancer: Effect of Lesion Size, Smoothing Filter, and Partial-Volume Correction on PROMISE Criteria.

Ortega C, Schaefferkoetter J, Veit-Haibach P, Anconina R, Berlin A, Perlis N, Metser U. Ortega C, et al. J Nucl Med. 2020 Nov;61(11):1615-1620. doi: 10.2967/jnumed.120.241737. Epub 2020 Mar 20. J Nucl Med. 2020. PMID: 32198311 Free article.

3

Convolutional neural networks for improving image quality with noisy PET data.

Schaefferkoetter J, Yan J, Ortega C, Sertic A, Lechtman E, Eshet Y, Metser U, Veit-Haibach P. Schaefferkoetter J, et al. Among authors: ortega c. EJNMMI Res. 2020 Sep 21;10(1):105. doi: 10.1186/s13550-020-00695-1. EJNMMI Res. 2020. PMID: 32955669 Free PMC article.

4

Quantitative ⁶⁸Ga-DOTATATE PET/CT Parameters for the Prediction of Therapy Response in Patients with Progressive Metastatic Neuroendocrine Tumors Treated with ¹⁷⁷Lu-DOTATATE.

Ortega C, Wong RKS, Schaefferkoetter J, Veit-Haibach P, Myrehaug S, Juergens R, Laidley D, Anconina R, Liu A, Metser U. Ortega C, et al. J Nucl Med. 2021 Oct;62(10):1406-1414. doi: 10.2967/jnumed.120.256727. Epub 2021 Feb 12. J Nucl Med. 2021. PMID: 33579805 Free PMC article.

5

Detection of clinically significant prostate cancer with ¹⁸F-DCFPyL PET/multiparametric MR.

Metser U, Ortega C, Perlis N, Lechtman E, Berlin A, Anconina R, Eshet Y, Chan R, Veit-Haibach P, van der Kwast TH, Liu A, Ghai S. Metser U, et al. Among authors: ortega c. Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3702-3711. doi: 10.1007/s00259-021-05355-7. Epub 2021 Apr 12. Eur J Nucl Med Mol Imaging. 2021. PMID: 33846845

6

Deep learning for whole-body medical image generation.

Schaefferkoetter J, Yan J, Moon S, Chan R, Ortega C, Metser U, Berlin A, Veit-Haibach P. Schaefferkoetter J, et al. Among authors: ortega c. Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):3817-3826. doi: 10.1007/s00259-021-05413-0. Epub 2021 May 22. Eur J Nucl Med Mol Imaging. 2021. PMID: 34021779

7

¹⁸F-DCFPyL (PSMA) PET in the Management of Men with Biochemical Failure after Primary Therapy: Initial Clinical Experience of an Academic Cancer Center.

Metser U, Ortega C, Hussey D, Chan R, Berlin A, Finelli A, Veit-Haibach P. Metser U, et al. Among authors: ortega c. Curr Oncol. 2021 Aug 25;28(5):3251-3258. doi: 10.3390/curroncol28050282. Curr Oncol. 2021. PMID: 34449586 Free PMC article.

8

Influence of sarcopenia, clinical data, and 2-[¹⁸F] FDG PET/CT in outcome prediction of patients with early-stage adenocarcinoma esophageal cancer.

Anconina R, Ortega C, Metser U, Liu ZA, Suzuki C, McInnis M, Darling GE, Wong R, Taylor K, Yeung J, Chen EX, Swallow CJ, Bajwa J, Jang RW, Elimova E, Veit-Haibach P. Anconina R, et al. Among authors: ortega c. Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):1012-1020. doi: 10.1007/s00259-021-05514-w. Epub 2021 Sep 7. Eur J Nucl Med Mol Imaging. 2022. PMID: 34491404

9

The association between lesion tracer uptake on 68Ga-DOTATATE PET with morphological response to 177Lu-DOTATATE therapy in patients with progressive metastatic neuroendocrine tumors.

Metser U, Eshet Y, Ortega C, Veit-Haibach P, Liu A, K S Wong R. Metser U, et al. Among authors: ortega c. Nucl Med Commun. 2022 Jan 1;43(1):73-77. doi: 10.1097/MNM.0000000000001488. Nucl Med Commun. 2022. PMID: 34887370

10

The impact of PSMA PET on the treatment and outcomes of men with biochemical recurrence of prostate cancer: a systematic review and meta-analysis.

Pozdnyakov A, Kulanthaivelu R, Bauman G, Ortega C, Veit-Haibach P, Metser U. Pozdnyakov A, et al. Among authors: ortega c. Prostate Cancer Prostatic Dis. 2023 Jun;26(2):240-248. doi: 10.1038/s41391-022-00544-3. Epub 2022 Apr 19. Prostate Cancer Prostatic Dis. 2023. PMID: 35440642 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

492 results

Search Page